AstraZeneca Inks $555M AI-CRISPR Deal with Algen to Target Immunology
AstraZeneca has signed a $555 million milestone-based partnership with Algen Biotechnologies to deploy AI and CRISPR gene-editing together for immunology drug discovery.
Artificial Intelligence (AI) is the field of computer science focused on building machines and software capable of mimicking human cognitive processes. These include learning, reasoning, problem-solving, perception, and language understanding. AI encompasses a wide range of technologies, from rule-based systems and machine learning to advanced deep learning and generative models. It is applied in everyday tools such as voice assistants, recommendation systems, fraud detection, autonomous vehicles, and medical diagnostics. The goal of AI is to enable systems to make decisions, adapt to new information, and operate with varying degrees of autonomy.
AstraZeneca has signed a $555 million milestone-based partnership with Algen Biotechnologies to deploy AI and CRISPR gene-editing together for immunology drug discovery.
OpenAI has entered into a strategic agreement with AMD to supply high-performance AI chips, diversify its hardware sources, and build next-gen compute capacity.
Elon Musk has broken new ground, achieving a net worth of $500 billion – the first time any person has ever crossed the half-trillion mark, according to Forbes.
Opera today introduced Neon, an AI-powered browser that can run tasks and navigate pages autonomously — aiming to shift web browsing from passive to “agentic.”
AI search startup Perplexity has reportedly raised $200 million at a $20 billion valuation, just two months after a $100 million round – signaling its rapid rise as a major rival to Google.